Search for Clinical Trial Results

Hyperphosphatemia - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia Condition: Hyperphosphatemia Date: 2016-07-14 Interventions:
|
Completed |
Study Name: A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia Condition: Hemodialysis Patients With Hyperphosphatemia Date: 2013-04-12 Interventions: Drug: PA21 |
Recruiting |
Study Name: Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) Condition: Hyperphosphatemia Date: 2016-02-09 Interventions: Drug: sucroferric oxyhydroxide The non-interventional design allows the observation of patients in a bro |
Recruiting |
Study Name: An Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia Condition: Hyperphosphatemia Date: 2016-02-17 Interventions:
|
Completed |
Study Name: Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease Condition: Hyperphosphataemia Date: 2014-05-28 Interventions:
|
Not yet recruiting |
Study Name: Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China Condition: Hyperphosphatemia Date: 2016-12-20 Interventions:
|
Recruiting |
Study Name: A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis Condition: Hyperphosphatemia Date: 2016-11-11 Interventions:
|
Completed |
Study Name: An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD) Condition: Hyperphosphatemia Date: 2016-02-03 Interventions:
|
Completed |
Study Name: Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients Condition: Hyperphosphatemia Date: 2012-01-18 Interventions: Drug: Lanthanum Carbonate (BAY77-1931) |
Completed |
Study Name: Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate Condition: Hyperphosphatemia Date: 2012-01-18 Interventions:
|